fda banning compounded semaglutide The Just Banned Semaglutide—Is Your Weight-Loss Plan in Trouble? FDA alerts health care providers,
Description
The global GLP-1 market is on a significant growth trajectory, anticipated to rise from an estimated $44.5 million in 2023 to $95.4 million by 2031,...
Leptin is a peptide hormone that plays a critical physiologic role in the human body, regulating appetite, food intake, and body weight by entering...
Recent estimates suggest that around 1.6 million adults used GLP-1 weight-loss drugs between early 2024 and early 2025, while broader data indicates up to 1.5 million people are currently taking them at any one time1
Nature's Sweetener Alternative
Sometimes self-care means saying YES to more
GLP-1 therapy doesn't require expensive brand names or insurance coverage
